Clinical Trials Directory

Trials / Completed

CompletedNCT01707446

Role of Cerebral Oximetry In Reducing Delirium After Complex Cardiac Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
250 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

Delirium after cardiac surgery is reported in a range of 3-47% of patients. Delirium is a serious complication that results in prolonged length of stay, increased health care costs and is associated with higher death rates. The exact cause involved in the development of delirium after cardiac surgery is unclear. The latest advancement in near-infrared spectroscopy (NIRS) Oximetry offers real-time management of patients at risk of brain injury. This approved device will monitor cerebral oxygenation during and 24hr after cardiac surgery, recording oxygenation in real time allowing the clinical team the opportunity to intervene early to prevent ischemia and possibly preventing untoward events. Adverse events followed include, but are not limited to, stroke, (transient ischemic attacks), heart attack, (myocardial infarction), clots found in lungs (pulmonary embolism), kidney failure, pneumonia, cause of death for 30-days after surgery (all cause mortality). Hypothesis: Perioperative restoration of rSO2 desaturation to baseline values results in lower delirium rates after complex cardiac surgery.

Conditions

Interventions

TypeNameDescription
DEVICECerebral oximetry monitor (The INVOS® Cerebral/Somatic Oximeter)In the intervention group, an alarm threshold at 75% of the baseline rSO2 value will be established. Based on predetermined algorithm the rSO2 will be maintained at or above 75% of the baseline measurements.
OTHERAn alarm threshold at 75% of the baseline rSO2 valueIf the threshold of \< 75% from baseline is reached for \> 1 minute an algorithm geared to restore rSO2 to baseline levels will be implemented.

Timeline

Start date
2012-01-01
Primary completion
2014-12-01
Completion
2016-08-01
First posted
2012-10-16
Last updated
2017-06-01

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01707446. Inclusion in this directory is not an endorsement.